Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) rose 0.3% during trading on Friday . The stock traded as high as $3.23 and last traded at $3.00. Approximately 14,194 shares traded hands during trading, a decline of 59% from the average daily volume of 34,444 shares. The stock had previously closed at $2.99.
Conduit Pharmaceuticals Price Performance
The stock’s fifty day simple moving average is $3.15 and its 200-day simple moving average is $3.16.
About Conduit Pharmaceuticals
Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.
Featured Stories
- Five stocks we like better than Conduit Pharmaceuticals
- Airline Stocks – Top Airline Stocks to Buy Now
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Basic Materials Stocks Investing
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Conduit Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conduit Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
